Syneos Health (SYNH) Declares Strategic Partnership With Oracle

Zacks2023-09-13

Syneos Health SYNH recently announced a strategic collaboration that will expand its relationship with Oracle. The partnership will utilize the Oracle Cerner Learning Health Network (“LHN”) and the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2367615517?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890","is_english":true,"pubTime":"2023-09-13 20:10","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2367615517","market":"us","top_or_hot":-1,"title":"Syneos Health (SYNH) Declares Strategic Partnership With Oracle","media":"Zacks","content":"<div>\n<p>Syneos Health SYNH recently announced a strategic collaboration that will expand its relationship with Oracle. The partnership will utilize the Oracle Cerner Learning Health Network (“LHN”) and the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/syneos-health-synh-declares-strategic-121000367.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Syneos Health (SYNH) Declares Strategic Partnership With Oracle</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSyneos Health (SYNH) Declares Strategic Partnership With Oracle\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-09-13 20:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/syneos-health-synh-declares-strategic-121000367.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Syneos Health SYNH recently announced a strategic collaboration that will expand its relationship with Oracle. The partnership will utilize the Oracle Cerner Learning Health Network (“LHN”) and the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/syneos-health-synh-declares-strategic-121000367.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0256863811.USD","symbol_name":"ALLIANZ US EQUITY \"A\" INC","start_time":0,"source_url":"https://finance.yahoo.com/news/syneos-health-synh-declares-strategic-121000367.html","article_id":"2367615517","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2367615517","pubTimestamp":1694607000,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Syneos Health SYNH recently announced a strategic collaboration that will expand its relationship with Oracle. The partnership will utilize the Oracle Cerner Learning Health Network  and the elements of Oracle’s suite of study startup solutions to help reduce the time taken to recruit patients for clinical studies and increase the diversity of patient populations participating in medical research.Through the latest development, Syneos Health is evolving its patient recruitment capabilities to further address unmet sponsor, site and patient needs.The Oracle Cerner LHN is a nationwide network of diverse health systems, ranging from small clinics to large hospitals that share de-identified, real-world data to help physicians advance clinical research. Through the combination of Oracle’s site selection capabilities, the Oracle Cerner LHN and SYNH’s clinical recruitment capabilities, the companies aim to provide physicians with greater access to a diverse set of data to bring clinical trial","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","LU0433182093.SGD":"First Eagle Amundi International AS-C SGD","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","BK4534":"瑞士信贷持仓","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","BK4585":"ETF&股票定投概念","ORCL":"甲骨文","BK4533":"AQR资本管理(全球第二大对冲基金)","SYNH":"Syneos Health, Inc.","LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4082":"医疗保健设备","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","LU1935043536.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME \"AA\" (SGDHDG) INC A","LU0889565833.HKD":"FRANKLIN TECHNOLOGY \"A\" (HKD) ACC","LU0082616367.USD":"摩根大通美国科技A（dist）","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","LU1803068979.SGD":"FTIF - Franklin Technology A (acc) SGD-H1","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","SIBN":"SI-BONE, Inc.","BK4198":"医疗保健用品","QTRX":"Quanterix Corp","HAE":"美国血液技术","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","LU0109392836.USD":"富兰克林科技股A","BK4097":"系统软件","LU1489326972.SGD":"First Eagle Amundi International AHS-MD SGD-H","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC","LU0861579265.USD":"联博低波幅策略股票基金A","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4530":"医药外包概念","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","BK4528":"SaaS概念","LU0985489474.SGD":"First Eagle Amundi International AHS-C SGD-H","BK4516":"特朗普概念","LU0878866978.SGD":"First Eagle Amundi International AHS-QD SGD-H"},"translate_title":"Syneos Health宣布与甲骨文建立战略合作伙伴关系","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYNH":1,"SIBN":1,"QTRX":1,"ORCL":1,"HAE":1},"content_text":"Syneos Health SYNH recently announced a strategic collaboration that will expand its relationship with Oracle. The partnership will utilize the Oracle Cerner Learning Health Network (“LHN”) and the elements of Oracle’s suite of study startup solutions to help reduce the time taken to recruit patients for clinical studies and increase the diversity of patient populations participating in medical research.\nThrough the latest development, Syneos Health is evolving its patient recruitment capabilities to further address unmet sponsor, site and patient needs.\nNews in Detail\nThe Oracle Cerner LHN is a nationwide network of diverse health systems, ranging from small clinics to large hospitals that share de-identified, real-world data to help physicians advance clinical research. Through the combination of Oracle’s site selection capabilities, the Oracle Cerner LHN and SYNH’s clinical recruitment capabilities, the companies aim to provide physicians with greater access to a diverse set of data to bring clinical trial opportunities to a broader group of patients and speed new therapies to the market.\nImage Source: Zacks Investment Research\nThe complexity of the current clinical research recruitment process makes it difficult to reach diverse populations and deliver much-needed treatments to the market timely. SYNH’s enhanced collaboration with Oracle demonstrates its intention of continued investments in technology and data solutions that accelerate clinical development and optimize performance for customers.\nIndustry Prospects\nPer a Research report, the global eClinical solution market was valued at $7.89 billion in 2022 and is expected to witness a CAGR of 13.9% by 2030.\nRecent Collaborations\nOf late, Syneos Health is increasing its focus on the expansion of clinical trial capabilities through new partnership deals. The company’s innovative Catalyst Site Program, launched in 2016, streamlines each aspect of the clinical development process and supports the development of new methodologies to bring therapies to patients faster.\nLast month, the program was expanded to Mainland China via SYNH’s agreement with Union Hospital, Tongji Medical College and the Huazhong University of Science and Technology (“Wuhan Union Hospital”). In addition, Syneos Health also announced a collaboration with Aotearoa Clinical Trials in New Zealand and the University Malaya Medical Centre in Malaysia, expanding the company’s clinical trial capabilities across a broader range of therapeutic areas in the respective countries.\nPrice Performance\nIn the past six months, Syneos Health shares have increased 22.8% against the industry’s fall of 15.9%.\nZacks Rank and Key Picks\nSyneos Health currently carries a Zacks Rank #3 (Hold).\nSome better-ranked stocks in the broader medical space are Haemonetics HAE, Quanterix QTRX and SiBone SIBN, each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.\nHaemonetics’ stock has risen 15% in the past year. Earnings estimates for Haemonetics have increased from $3.56 to $3.74 in 2023 and $3.96 to $4.07 in 2024 in the past 30 days.\nHAE’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 19.39%. In the last reported quarter, it posted an earnings surprise of 38.16%.\nEstimates for Quanterix’s 2023 loss per share have narrowed from $1.19 to 97 cents in the past 30 days. Shares of the company have increased 159.4% in the past year against the industry’s decline of 4.1%.\nQTRX’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 30.39%. In the last reported quarter, it posted an earnings surprise of 55.56%.\nEstimates for SiBone’s 2023 loss have narrowed from $1.42 to $1.27 per share in the past 30 days. Shares of the company have increased 23.1% in the past year against the industry’s fall of 2.1%.\nSIBN’s earnings beat estimates in all the trailing four quarters, the average surprise being 20.37%. In the last reported quarter, SiBone delivered an earnings surprise of 26.83%.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nHaemonetics Corporation (HAE) : Free Stock Analysis Report\nQuanterix Corporation (QTRX) : Free Stock Analysis Report\nSyneos Health, Inc. (SYNH) : Free Stock Analysis Report\nSiBone (SIBN) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2367615517"}